The associations of tobacco use, sexually transmitted infections, HPV vaccination, and screening with the global incidence of cervical cancer: an ecological time series modeling study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: We aimed to quantify the temporal associations between cervical cancer incidence and cervical cancer-related factors and to predict the number of new cervical cancer cases averted under counterfactual scenarios compared to the status quo scenario. METHODS: We described temporal trends in cervical cancer and associated factors globally from 1990 to 2019. We then used generalized linear mixed models to explore the impact of tobacco use, sexually transmitted infections (STIs), human papillomavirus (HPV) vaccination, and cervical screening on cervical cancer incidence. A counterfactual analysis was performed to simulate the most effective scenario for reducing cervical cancer incidence. RESULTS: The worldwide incidence of cervical cancer showed a downward trend over the past 3 decades (estimated annual percentage change, -0.72%), although the incidence remained high (>30 cases per 100,000 persons) in sub-Saharan Africa, Latin America, and the Caribbean. Higher smoking and STI prevalence showed significant direct associations with the incidence of cervical cancer, whereas HPV vaccination and screening coverage showed significant inverse associations. If the strategic goals for accelerating the elimination of cervical cancer and tobacco control programs had been achieved in 2019, the largest decrease in the number of new cervical cancer cases would have been observed, with 54,169 fewer new cases of cervical cancer in 2019. CONCLUSIONS: Our counterfactual analysis found that a comprehensive intervention program emphasizing scaled-up cervical screening coverage (70%), HPV vaccination coverage (90%), and tobacco control (30% relative reduction) would be the most effective program for reducing cervical cancer incidence.
Abstract
OBJECTIVES: We aimed to quantify the temporal associations between cervical cancer incidence and cervical cancer-related factors and to predict the number of new cervical cancer cases averted under counterfactual scenarios compared to the status quo scenario. METHODS: We described temporal trends in cervical cancer and associated factors globally from 1990 to 2019. We then used generalized linear mixed models to explore the impact of tobacco use, sexually transmitted infections (STIs), human papillomavirus (HPV) vaccination, and cervical screening on cervical cancer incidence. A counterfactual analysis was performed to simulate the most effective scenario for reducing cervical cancer incidence. RESULTS: The worldwide incidence of cervical cancer showed a downward trend over the past 3 decades (estimated annual percentage change, -0.72%), although the incidence remained high (>30 cases per 100,000 persons) in sub-Saharan Africa, Latin America, and the Caribbean. Higher smoking and STI prevalence showed significant direct associations with the incidence of cervical cancer, whereas HPV vaccination and screening coverage showed significant inverse associations. If the strategic goals for accelerating the elimination of cervical cancer and tobacco control programs had been achieved in 2019, the largest decrease in the number of new cervical cancer cases would have been observed, with 54,169 fewer new cases of cervical cancer in 2019. CONCLUSIONS: Our counterfactual analysis found that a comprehensive intervention program emphasizing scaled-up cervical screening coverage (70%), HPV vaccination coverage (90%), and tobacco control (30% relative reduction) would be the most effective program for reducing cervical cancer incidence.
참고문헌 (41)
- Fakhry C, "Clinical implications of human papillomavirus in head and neck cancers", J Clin Oncol, 24, pp.2606~2611 (2006)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- Arbyn M, "Estimates of incidence and mortality of cervical cancer in 2018 : a worldwide analysis", Lancet Glob Health, 8, pp.e191~e203 (2020)
- Ginsburg O, "The global burden of women’s cancers : a grand challenge in global health", Lancet, 389, pp.847~860 (2017)
- Laprise JF, "Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States", Ann Intern Med, 172, pp.22~29 (2020)
- Palmer T, "Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland : retrospective population study", BMJ, 365, pp.l1161~ (2019)
- Schiffman M, "Chapter 2 : natural history of anogenital human papillomavirus infection and neoplasia", J Natl Cancer Inst Monogr, pp.14~19 (2003)
- de Sanjosé S, "The natural history of human papillomavirus infection", Best Pract Res Clin Obstet Gynaecol, 47, pp.2~13 (2018)
- Guidry JT, "The interaction between human papillomavirus and other viruses", Virus Res, 231, pp.139~147 (2017)
- "Cervarix"[URL]
- "Launch of the global strategy to accelerate the elimination of cervical cancer"[URL]
- GBD 2019 Diseases and Injuries Collaborators, "Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019", Lancet, 396, pp.1204~1222 (2020)
- GBD 2017 Causes of Death Collaborators, "Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017 : a systematic analysis for the Global Burden of Disease Study 2017", Lancet, 392, pp.1736~1788 (2018)
- Cortessis VK, "Intrauterine device use and cervical cancer risk : a systematic review and meta-analysis", Obstet Gynecol, 130, pp.1226~1236 (2017)
- Ghosh C, "Dietary intakes of selected nutrients and food groups and risk of cervical cancer", Nutr Cancer, 60, pp.331~341 (2008)
- Koshiyama M, "The effects of the dietary and nutrient intake on gynecologic cancers", Healthcare(Basel), 7, pp.88~ (2019)
- GBD 2019 Tobacco Collaborators, "Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019 : a systematic analysis from the Global Burden of Disease Study 2019", Lancet, 397, pp.2337~2360 (2021)
- "Cervical cancer screening: response by country" (2020)[URL]
- "Human papillomavirus (HPV) vaccination coverage"[URL]
- Dhillon PK, "Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976-2005 : an age-period-cohort analysis", Br J Cancer, 105, pp.723~730 (2011)
- Gao S, "Declining rates of hepatocellular carcinoma in urban Shanghai : incidence trends in 1976-2005", Eur J Epidemiol, 27, pp.39~46 (2012)
- "Introduction to generalized linear mixed models"[URL]
- Portet S, "A primer on model selection using the Akaike information criterion", Infect Dis Model, 5, pp.111~128 (2020)
- "World Health Assembly adopts global strategy to accelerate cervical cancer elimination" (2020)[URL]
- "WHO Framework Convention of Tobacco Control. Contribution and impact of implementing the WHO FCTC on achieving the noncommunicable disease global target on the reduction of tobacco use" (2018)[URL]
- Ogilvie G, "A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada : parental factors associated with HPV vaccine receipt", PLoS Med, 7, pp.e1000270~ (2010)
- Simms KT, "Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99 : a modelling study", Lancet Oncol, 20, pp.394~407 (2019)
- Raychaudhuri S, "Current status of knowledge, attitude and practice(KAP)and screening for cervical cancer in countries at different levels of development", Asian Pac J Cancer Prev, 13, pp.4221~4227 (2012)
- Wigle J, "Human papillomavirus(HPV)vaccine implementation in low and middle-income countries(LMICs) : health system experiences and prospects", Vaccine, 31, pp.3811~3817 (2013)
- Belete N, "Willingness and acceptability of cervical cancer screening among women living with HIV", AIDS in Addis Ababa, Ethiopia : a cross sectional study, 2015, pp.2, 6~
- Botwright S, "Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects", PLoS One, 12, pp.e0182663~ (2017)
- Unemo M, "Sexually transmitted infections : challenges ahead", Lancet Infect Dis, 17, pp.e235~e279 (2017)
- GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015", Lancet, 388, pp.1545~1602 (2016)
- Peeling RW, "Rapid tests for sexually transmitted infections(STIs) : the way forward", Sex Transm Infect, 82(Suppl 5), pp.v1~v6 (2006)
- Ylitalo N, "Smoking and oral contraceptives as risk factors for cervical carcinoma in situ", Int J Cancer, 81, pp.357~365 (1999)
- Hecht SS, "Tobacco carcinogens, their biomarkers and tobacco-induced cancer", Nat Rev Cancer, 3, pp.733~744 (2003)
- Alexandrov LB, "Mutational signatures associated with tobacco smoking in human cancer", Science, 354, pp.618~622 (2016)
- "WHO global report on trends in prevalence of tobacco use 2000–2025, third edition" (2019)[URL]
- Jafari A, "National, regional, and global prevalence of cigarette smoking among women", females in the general population : a systematic review and meta-analysis, 2021, pp.26, 5~
- Ding D, "An early-stage epidemic : a systematic review of correlates of smoking among Chinese women", Int J Behav Med, 21, pp.653~661 (2014)
- Torres OV, "Stress is a principal factor that promotes tobacco use in females", Prog Neuropsychopharmacol Biol Psychiatry, 65, pp.260~268 (2016)
